Appili Therapeutics Inc.

TSX:APLI Voorraadrapport

Marktkapitalisatie: CA$4.2m

Appili Therapeutics Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Appili Therapeutics has a total shareholder equity of CA$-12.4M and total debt of CA$10.1M, which brings its debt-to-equity ratio to -81.2%. Its total assets and total liabilities are CA$2.2M and CA$14.6M respectively.

Belangrijke informatie

-81.2%

Verhouding schuld/eigen vermogen

CA$10.05m

Schuld

Rente dekkingsration/a
ContantCA$301.27k
Aandelen-CA$12.39m
Totaal verplichtingenCA$14.62m
Totaal activaCA$2.23m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Market Sentiment Around Loss-Making Appili Therapeutics Inc. (TSE:APLI)

Mar 24
Market Sentiment Around Loss-Making Appili Therapeutics Inc. (TSE:APLI)

Appili Therapeutics Inc.'s (TSE:APLI) Shift From Loss To Profit

Dec 09
Appili Therapeutics Inc.'s (TSE:APLI) Shift From Loss To Profit

Analyse van de financiële positie

Kortlopende schulden: APLI has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Langlopende schulden: APLI has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: APLI has negative shareholder equity, which is a more serious situation than a high debt level.

Schuld verminderen: APLI's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: APLI has less than a year of cash runway based on its current free cash flow.

Voorspelling contante baan: APLI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 6.1% each year


Ontdek gezonde bedrijven